- Global Pharma News & Resources

Automatic Cell Imaging System Market Analysis and Trends 2020 – Global Industry Growth by Size, Share, Demand, Replacement Surgeries, Advanced Technology, Emerging Market and Forecast to 2026

Live cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in the first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.

Request a sample copy of this report@

Cell imaging has become an important tool in medical research. Automatic microscopy and image analysis are used to study a variety of different things such as the influence of chemical compounds on cell development. Researchers in this field primarily want to see which compounds capture the cell cycle or the time they take to incubate and at what concentration. Cell cycle is a rigid sequence of phases that a cell undergoes while it is on its dividing phase. If anything goes wrong at some stage during the transition from one phase to other, the cell generally enters cell death that is programmed. Studying these procedures needs intricate image analysis workflows that can be mind-numbing to ascertain. This process is sped up by the use of modular software. Automated cell imaging also finds application in drug discovery processes for various diseases, for instance, cancer drugs.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @

Automatic Cell Imaging System Market – Dynamics

As the incidence of cancer is rising at an alarming rate, so is the need for automatic cell imaging systems. Automatic cell imaging systems offer grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.

Rising prevalence of cancer is expected to propel the automatic cell imaging system market over the forecast period. According to the World Cancer Research Fund International (WCRFI), in 2012, an estimated 14.1 million cancer cases were reported worldwide, out of which, around 7.4 men and 6.6 million women were diagnosed. As per WCRFI, it is predicted that by 2035 cancer incidence will increase to 24 million. The most common cancers are breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases).

Rising product approvals and launches by the market players is expected to propel the market growth. For instance, in February 2018, Molecular Devices, LLC, launched ImageXpress Pico Automated Cell Imaging System which automates manual procedures such as acquisition steps and post processing of images and offers user-efficient tool in research work

To understand Research Methodology, please click

Automatic Cell Imaging System Market – Regional Insights

North America held the maximum market share in automatic cell imaging system market globally. Rising incidences of cancer cases in the region is expected to bolster the market growth. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Moreover, according to a report published in American Cancer Society’s Cancer Journal for Clinicians, around 1,735,350 new cancer cases are estimated to be diagnosed in 2018 in the U.S., including around 87,290 cases of melanoma.

Favorable and constructive policies and regulations, as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of automatic cell imaging system from governing bodies, are likely to fuel the growth of the automatic cell imaging system market in North America.

The automated microscopy process generates hundreds and thousands of images in a matter of few days; hence, potent image analysis software is required to differentiate between the various appearances of the cell. Manufacturers of automated microscopes generally offer image analysis software for analyzing images that are produced by their hardware. The complexity with this software is to discover the right approach for a definite assay. The analysis desires robustness in order to cope with various situations and they should be fast enough to compute the results for a huge amount of images generated in a short time.

Automatic Cell Imaging System Market Taxonomy:

On the basis of product, automatic cell imaging system market segmented into:

  • Phase contrast microscopy
  • Fluorescent microscopy
  • Quantitative phase contrast microscopy

On the basis of end user, automatic cell imaging system market segmented into:

  • Research centers
  • Hospitals
  • Others

On the basis of region, automatic cell imaging system market segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

To get detailed table of content (ToC), please click –

Key players in the automatic cell imaging system market:

Some of the key players operating in the automatic cell imaging system market includes GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer., Inc.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 16-Feb-2021